Nan LiinObvious VenturesInvesting in Iterative ScopesBringing personalized medicine to gastroenterology4 min read·Aug 3, 2021----
Nan LiinObvious VenturesTo RXRX and BeyondTheir IPO is another milestone along a longer journey for Recursion.4 min read·Apr 16, 2021--1--1
Nan LiinObvious VenturesPromoting Meera Clark to PrincipalLeveling up the Obvious Investment Team3 min read·Mar 8, 2021--4--4
Nan LiinObvious VenturesInvesting in DexterityFreeing robots from cages, and pioneering the next generation of industrial robotics4 min read·Jul 21, 2020--1--1
Nan LiinObvious VenturesInvesting in Inato95% of the eligible patients for a clinical trial are never considered. It’s time for a transformation.5 min read·Feb 4, 2020----
Nan LiinWorld PositiveThe New BiologyA counterintuitive approach to biological design challenges9 min read·Oct 29, 2019----
Nan LiinObvious VenturesInvesting in LabGeniusAdvancing protein therapies using computational biology4 min read·Oct 23, 2019----
Nan LiinWorld PositiveIndustrial IQ: Where High Tech Meets Low TechTech is breaking out of the Silicon Valley sandbox, transforming traditional, trillion-dollar industries in the process.10 min read·Apr 30, 2019--1--1
Nan LiinObvious VenturesOur Investment in DarwinAIDriving towards a safe, high performance future for AI3 min read·Sep 25, 2018----
Nan LiinObvious VenturesWelcome Will Dzierson!Designer in Residence at Obvious Ventures3 min read·Jul 17, 2018----